YCR.png

KIDNEY CANCER SCREENING

A new study, led by researchers at the University of Cambridge, will investigate the feasibility of developing a full kidney cancer screening clinical trial.

The CRUK Urological Malignancies Programme is a synergistic conglomerate of scientists and clinicians working on multimodal laboratory, clinical and translational research strategies towards the common goal of improving outcomes for patients with urological cancers. Our programme members engage leading-edge techniques and approaches to elucidate the underlying genetics and biological mechanisms of urological malignancies, develop and assess optimal pathways for their clinical diagnosis and management, and improve the therapy pathways of patients using novel biopsy, imaging and treatment methods. Find out more...

Latest news...

The Cambridge Urological Malignancies Programme is part of the CRUK Cambridge Centre, funded by Cancer Research UK Major Centre Award C9685/A25117, and supported by the NIHR Cambridge BRC.